July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
The Successful Treatment of Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Keratitis with a Topical β-Lactam Antibiotic
Author Affiliations & Notes
  • John Eric Romanowski
    The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Eric G Romanowski
    The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Kathleen A Yates
    The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Regis P Kowalski
    The Charles T. Campbell Ophthalmic Microbiology Laboratory, UPMC Eye Center, Ophthalmology and Visual Sciences Research Center, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States
  • Footnotes
    Commercial Relationships   John Romanowski, None; Eric Romanowski, None; Kathleen Yates, None; Regis Kowalski, None
  • Footnotes
    Support  PA Lions Sight Conservation & Eye Research Foundation, NIH Core Grant EY08098, RPB, Eye & Ear Foundation
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 3658. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      John Eric Romanowski, Eric G Romanowski, Kathleen A Yates, Regis P Kowalski; The Successful Treatment of Experimental Methicillin-Resistant Staphylococcus aureus (MRSA) Keratitis with a Topical β-Lactam Antibiotic. Invest. Ophthalmol. Vis. Sci. 2018;59(9):3658.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The systemic treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections with β-lactam (β-L) antibiotics is contraindicated due to resistance of the bacteria. However, it is unknown if this resistance can be overcome by an excessive amount of drug delivered directly to the site of infection. The goal of the current study was to determine a “Proof of Principle” whether a topical β-lactam antibiotic (i.e. penicillin), in a high concentration, can overcome resistance and successfully treat an MRSA corneal infection using a rabbit keratitis model.

Methods : The corneas of both eyes of 32 rabbits were intrastromally infected with 2000 CFU of MRSA strain K950. The corneal epithelium was removed in the left eyes to mimic corneal ulceration while the epithelium remained in the right eyes. After 4 hours, 8 rabbits were euthanized to determine amounts of corneal bacteria at the onset of treatment. The remaining rabbits were divided into 3 treatment groups (n=8): 1) β-lactam antibiotic (6% penicillin) (β-L); 2) 2.5% vancomycin (VAN); 3) saline (SAL). The rabbits were treated topically in both eyes every 15’ for 5h. One hour after treatment, the rabbits were euthanized and the amounts of corneal bacteria from the treatment groups determined and analyzed for treatment effectiveness and bactericidal effect.

Results : β-L was more effective than VAN in reducing MRSA when the corneal epithelium was removed (P≤0.05 Kruskal-Wallis), but was only as effective as VAN when the corneal epithelium remained (P≥0.05 K-W). Both treatments reduced colony counts compared to SAL with and without epithelium (P≤0.05 K-W). β-L was bactericidal (≥99.9% decrease in median colony counts compared to the onset of treatment) in eyes with and without epithelium while VAN was only bactericidal in eyes without epithelium.

Conclusions : We demonstrated a “Proof of Principle” that a β-lactam antibiotic can overcome resistance to successfully treat MRSA keratitis in a rabbit model. The β-lactam antibiotic was as or more effective than the standard of care, 2.5% vancomycin, depending if the corneal epithelium was removed, which can affect drug penetration. Additional studies are warranted to determine whether β-lactam antibiotics can be used as a potential alternative treatment for MRSA keratitis.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×